Media OutReach

Bora 3Q25 Delivers Renewed Profitability as Efficiency and Scale Improves

Published

4 months ago

13/11/2025

Strategic realignment powering Bora’s dual-engine businesses model

HONG KONG SAR – Media OutReach Newswire – 13 November 2025 – Bora Pharmaceuticals (TWSE: 6472) today announced its financial results and operational highlights for third quarter of 2025.

Quarterly Business and Financial Highlights

Company reported quarterly basic EPS of NT$5.09, with a loss per share of NT$1.49 from discontinued operations. Operating income reached NT$1,063 million and net income for continued operations came in at NT$822 million, resulting in quarterly EBITDA of NT$1,283 million, well on track to reclaim 2023 core P&L indicators.
By the end of 3Q25, Bora’s operational integration and strategic streamlining efforts have been fully executed, meeting all targeted objectives. This milestone has led to a record-high CDMO business profitability, clear evidence that Bora’s dual-engine model is now entering its next phase of balanced but scalable growth.
Fueled by expanded capacity and the addition of new dosage forms, Bora’s CDMO business grew 56.5% year-to-date through 3Q25, reaching over NT$7.3 billion and returning to a sequential growth trajectory.
Pharma sales revenues fluctuated as legacy inventory phased out, and new products are still awaiting approvals. Generics portfolio competitiveness remains a key focus area in the near term. Led by Vigafyde, Bora’s rare disease portfolio continued to gain impressive market share with the vigabatrin franchise across three dosage forms continues. The Company targets to file its next specialty pharma product by year end to accelerate the rare neurology disease business. The Company also targets to market branded Deflazacort tablets by 2025 year end as a new driver for the business.
The Company expects NTD to remain in the range of NTD 30-31 per USD for its operational planning.
Share capital increased 19.99% during the quarter from stock dividend distribution, employee stock option exercise and convertible bond conversions.
The Board approved Level-1 ADR issuance with each ADR share corresponding to 1/5 common share and total ADR issuance <10% of outstanding shares to enhanced market trust and investor service.

Mr. Bobby Sheng, Chairman of Bora Group, stated, “Bora executed a record level of post-merger CAPEX investment in 2025 and we are progressing in line with our strategic plan. We have expanded our Maryland aseptic fill/finish capacity by approximately 10% while solid and liquid dosage capacity in Minneapolis and Mississauga grew around 3%. The investments allowed Bora to increase our operational efficiency and increase revenue per headcount in the CDMO business by ~30% during the quarter compared to beginning of the year.

The CDMO backlog rose to US$296 million, driven by 27 new contracts and over 20 new molecules year-to-date, providing solid visibility into 2026 with 72% commercialized projects. Bora continues to leverage a unified CDMO network to enhance cost competitiveness for our very own Upsher-Smith generics portfolio, while paving the way for selective in-house manufacturing of specialty assets in the U.S.

As we look ahead, Bora is entering a phase of disciplined expansion and broader global recognition. Across our CDMO facilities in Asia and North America, we continue to actively navigate tariff and geopolitical challenges and turn them into new opportunities, strengthening supply chain resilience, and deepening collaboration with multinational partners.

On the pharma sales side, we continue to shed legacy low margin generics, increase our cashflow, and focus on our high-value generics pipeline, with certain PIV opportunities progressing to maturity in 2026. We remain dedicated on enhancing portfolio quality and increasing our Branded assets through selective specialty drugs, in order to build a more predictable and margin-accretive revenue base that mitigates product commoditization and price degredation.

In parallel, we are expanding our capital-market reach into the United States through the OTCQX Level-1 ADR program. We believe the Bora ADR will improve access and transparency for global institutional investors, while enabling overseas employees to participate in Bora’s growth. With no dilution and increasing visibility, we are laying the foundation for a stronger and more global 2026, defined by scaled growth, operational synergies, and increasing investor confidence.

3Q2025 Operational Achievements & Full Year Outlook

Global CDMO Operations

Global CDMO Operations (excluding intercompany orders from Upsher-Smith) revenues arrived at NT$1.78 billion in the third quarter and back to the sequential growth zone, representing approximately 37.13% of total revenue. A total of 418 million doses were developed and manufactured. Revenue contribution from global top 20 pharmaceutical companies remained steady at approximately 33%. Year-to-date, CDMO revenues grew 18.98% over last year and reached NT$5.27 billion. Bora continues to execute on expanding this customer base to enhance business visibility and stability.

As the Company ramps up its Maple Grove site, the momentum for U.S. manufacturing has been encouraging. Several clinical-stage clients are now transitioning into long-term strategic partnerships, with project scale and client size both increasing. Maple Grove is well positioned to be the Center of Excellence for scale-up and U.S. supply-chain integration for Bora.
Large molecule CDMO operation revenues saw nearly 50% increase over the previous quarter, driven by one new ADC client and several change orders in addition to Cipla’s own labeled product launch under the collaboration agreement. Positioned as a one-stop CDMO platform alongside Bora Pharmaceuticals, Bora Biologics is now fully accelerating its CDMO operations

Pharma Sales Operations

Pharma Sales Operations in the third quarter reached a revenue of NT$3.02 billion, down 6.4% YoY, primarily due to discontinuing several products under significant pricing pressure. Pharma Sales accounted for approximately 62.83% of total revenues.

Discontinued loss per share (from the closure of the Plymouth production area) reflected the clearance sale of higher-cost inventories from Upsher-Smith’s legacy generics and internal supply transfer delayed by regulatory hurdles. These inventory clearance sales are now nearing completion. The greater-than-expected pricing pressure across our low margin generics reinforces the need to accelerate Bora’s transition toward higher-value and Branded specialty pharma products.
The Vigabatrin franchise market share expansion continues with the “total patient” indicator seeing breakthrough in October.
Bora continues to focus on DEE (Developmental and Epileptic Encephalopathies), where legacy compounds fail to meet significant unmet needs. The market is poised for new NCE entrants, expanding the addressable opportunity to roughly US$10 billion over the next 3–5 years. Bora aims to capture this growth through a Ready-to-Use 505(b)(2) pipeline and branded generics.

Recent Investor Conference

Bora will host an English online earnings call at 8:00 p.m. Taiwan time on Nov. 13^th, 2025, followed by an investor conference hosted by Taishin Securities at the Regent Taipei at 2:30 p.m. on Nov. 14^th, 2025. Both events will cover the company’s Q3’25 financial and business results and outlook.

English Online Earnings Presentation Link: https://events.q4inc.com/attendee/477519089

Bora will participate in the JP Morgan Healthcare Conference in January in San Francisco. For 1:1 meetings with management, please contact your JP Morgan representative.

Bora 2025 Earnings Schedule
Q4 2025: Expected in the 2^nd week of March 2026

Hashtag: #BoraPharmaceuticals

The issuer is solely responsible for the content of this announcement.

About Bora

Founded in 2007, Bora Pharmaceuticals (“Bora” or “the Company”, 6472.TW) is a leading pharmaceutical services company with a vision and goal of “Contributing to Better Health All Over the World”. Operating under a “Dual Engine” model that integrates CDMO and commercial expertise, we empower pharmaceutical and biotech partners to optimize product development, accelerate launches, and scale supply to meet global patient needs. At the same time, we actively broaden R&D and sales infrastructure, focusing on niche and rare disease markets to improve patients’ quality of life.

By investing in talent, infrastructure, and biologics expansion, Bora continues to transform operations and achieve sustainable growth. For more information, visit www.bora-corp.com.

Disclaimer:

This document and the accompanying information may contain forward-looking statements. All statements regarding the company’s future business operations, potential events, and prospects (including but not limited to forecasts, targets, estimates, and operational plans) are considered forward-looking statements unless they refer to factual occurrences. Forward-looking statements are subject to various factors and uncertainties that may cause significant differences from actual results, including but not limited to price fluctuations, actual demand, exchange rate variations, market share, competitive conditions, changes in the legal, financial, and regulatory framework, international economic and financial market conditions, political risks, cost estimates, and other risks and variables beyond the company’s control. These forward-looking statements are based on current predictions and assessments, and the company disclaims any responsibility for future updates.

Media OutReach

AECOM supports CEDD and AFCD of HKSAR Government in launching Hong Kong’s first comprehensive nature-based solutions guidelines to advance sustainable urban development

Published

7 hours ago

10/03/2026

Media Outreach

HONG KONG SAR – Media OutReach Newswire – 10 March 2026 – AECOM, the trusted global infrastructure leader, supported the release of the Hong Kong Nature-based Solutions Design Guidelines (HKNbSDG), a first-of-its-kind guidelines developed for the Civil Engineering Development Department (CEDD) and the Agriculture, Fisheries and Conservation Department (AFCD) of the HKSAR Government. The HKNbSDG helps government agencies, designers, planners and built environment professionals in integrating nature-based solutions (NbS) into urban development projects across Hong Kong.

Developed through multidisciplinary expertise in ecology, landscape architecture, engineering, climate resilience and urban planning, the HKNbSDG provides a practical blueprint for designing, implementing, sustainably managing, and evaluating NbS across diverse environmental contexts — from rivers and wetlands to coastlines and high-density urban districts.

Factoring in the characteristics of Hong Kong’s natural ecology and urban development, the HKNbSDG is built on three core principles that outline a holistic approach to promoting ecosystem diversity at multiple scales, embracing human-nature coexistence for mutual benefits, and improving resilience through NbS. It also includes a performance evaluation framework to support evidence-based decision-making and features local case studies, including Long Valley Nature Park and Tung Chung East Eco-shoreline.

“The HKNbSDG reflects our commitment to advancing nature‑positive design and supporting Hong Kong’s journey toward climate resilience and sustainable growth,” said Dr. Johnny Cheuk, senior vice president and Hong Kong executive leader at AECOM. “By integrating ecological science into design practice, we aim to empower practitioners to harness nature’s potential in building climate-resilient infrastructure.”

The HKNbSDG was officially launched at the Promulgation Ceremony held on March 3, 2026, at Long Valley Nature Park. The event was officiated by Miss. Diane Wong Shuk-han, JP, Under Secretary for Environment and Ecology; Mr. David Lam Chi-man, JP, Under Secretary for Development; Mr. Charles Karangwa, Global Head of Nature-based Solutions Centre of the International Union for Conservation of Nature (IUCN); Ir Michael Fong Hok-shing, JP, Director of Civil Engineering and Development; and Mr. Mickey Lai Kin-ming, JP, Director of Agriculture, Fisheries and Conservation.

The ceremony featured an introduction to the HKNbSDG by Stephen Suen, director of landscape architecture at AECOM, followed by a panel discussion on building cross-sector partnerships to reverse nature and biodiversity loss through NbS.

Panelists included:

Mr. Charles Karangwa, Global Head, Nature-based Solutions Centre, IUCN
Ir. Michael Fong Hok‑shing, JP, Director of Civil Engineering and Development
Mr. Mickey Lai Kin Ming, JP, Director of Agriculture, Fisheries and Conservation
Ms. Frances Chen, Director, Sustainability & Climate Change, North Asia, HSBC
Mr. Benny Au, Senior Manager, Sustainable Development, Swire Properties Limited

The release of the HKNbSDG supports Hong Kong’s key policy commitments, including the Climate Action Plan 2050 and its biodiversity conservation targets, by providing a practical roadmap for enhancing urban resilience and expanding green infrastructure. This publication equips practitioners with essential tools — from integrating ecology into early planning to designing for multifunctional benefits — grounded in Hong Kong-specific experience. It also serves as a central resource for advancing the Northern Metropolis development strategy, where NbS is helping to drive urban-rural integration and foster the co-existence of urban development and ecological conservation.

The HKNbSDG forms part of AECOM’s broader mission to help cities adapt to climate risks while enhancing quality of life. By bringing together global best practices and local ecological insights, AECOM aims to strengthen industry-wide capability in implementing NbS at scale.

Learn more about the Hong Kong Nature-based Solutions Design Guidelines here.

Download high-resolution images here.

Hashtag: #AECOM #NatureBasedSolutions #NaturePositive #ClimateResilience #Biodiversity

The issuer is solely responsible for the content of this announcement.

About AECOM

AECOM is the global infrastructure leader, committed to delivering a better world. As a trusted professional services firm powered by deep technical abilities, we solve our clients’ complex challenges in water, environment, energy, transportation and buildings. Our teams partner with public- and private-sector clients to create innovative, sustainable and resilient solutions throughout the project lifecycle – from advisory, planning, design and engineering to program and construction management. AECOM is a Fortune 500 firm that had revenue of US$16.1 billion in fiscal year 2025. Learn more at AECOM.

Media OutReach

Asian Computer Industry Online Exhibition 2026: A Global Hub for Technology Industry Collaboration

Published

7 hours ago

10/03/2026

Media Outreach

TAIPEI, TAIWAN –

Since its launch in 2022, the exhibition has been jointly organized by AsianNet and TradeAsia (www.e-tradeasia.com). The event has supported numerous companies in expanding into overseas markets and has earned strong industry recognition for high-quality buyers, efficient matchmaking, and measurable order results.

In 2026, ACI 2026 will expand in scale and be held concurrently with leading international technology trade shows, including Embedded World, Display Week (SID), COMPUTEX TAIPEI, and ISC High Performance. By aligning with major global exhibitions, the event creates a strong time-synergy effect, enabling international buyers to efficiently compare products, evaluate suppliers, and complete procurement decisions within a concentrated timeframe. This strategic alignment enhances purchasing efficiency and maximizes cross-exhibition business opportunities.

ACI 2026 features a robust lineup of respected Taiwanese manufacturers, including industry leaders such as HIGHGRADE TECH, OKAYO ELECTRONICS, BIPOLAR ELECTRONIC, YNG WEI, YNG YUH ELECTRONIC, ESMT, GOOD OPPORTUNITY ELECTRONIC, MSTRONIC, SUN RISE EXACT, AIRWAVE TECHNOLOGIES, KING DESGIN INDUSTRIAL, CLEVER INTELLIGENCE UNITY, YO-TRONICS TECHNOLOGY, DORIS INDUSTRIAL, REUEX INDUSTRIAL, ARIOSE ELECTRONICS, UNITEX NUNG LAI BUTTON and many more. These companies will present thousands of the latest computer industry products and technologies, covering a wide array of sectors crucial to modern manufacturing and production.

Comprehensive Coverage Across the Entire Industry Chain

The Asian Computer Industry Online Exhibition 2026 brings together dozens of premium suppliers from the global computer manufacturing and electronic components sectors, showcasing over a thousand innovative products and forward-looking technologies. The exhibits are strategically structured around the core value of the industry supply chain, comprehensively covering key system-level products such as desktop computers, laptops and accessories, tablets and accessories, industrial computers and embedded systems, gaming and e-sports equipment, as well as computer software, IT, and internet services.

The ACI 2026 also highlights critical communications infrastructure, including networking equipment, wireless communication devices, telecommunications and fiber access equipment, landline and VoIP systems, and antennas. In terms of key components and supply chain solutions, the showcased products include computer components, storage and memory devices, active components, power supply units, connectors and terminals, cables and cable assemblies, wiring accessories, transformers, batteries, and charging equipment.

In addition, the ACI 2026 features monitors, computer accessories and peripherals, input devices, point-of-sale (POS) systems, printers, plotters and scanners, printer consumables and parts, as well as broadcast and professional AV equipment, audio and video components, consumer electronics accessories and components, and electronic materials and supplies.

Together, these comprehensive categories fully demonstrate the complete ecosystem of the computer industry, spanning system integration, communications infrastructure, core components, and end-use applications. Combining technological depth with product breadth, the exhibition stands as a premier international trade event for efficient business matchmaking and global market expansion among professional buyers and industry stakeholders worldwide.

ACI 2026 Online Exhibition：
https://www.etradeasia.com/online-show/43/Asian-Computer-Industry-Online-Exhibition-2026.html

Innovative Online Exhibition Model

The Asian Computer Industry Online Exhibition 2026 features dedicated online showrooms, digital catalogs, and virtual exhibition halls fully integrated with the TradeAsia platform. Buyers worldwide can browse exhibitor information, submit quotation requests, and conduct procurement evaluations in real time, thereby facilitating efficient, cost-effective, and results-driven global business connections.

Hashtag: #TradeAsia

The issuer is solely responsible for the content of this announcement.

About TradeAsia

TradeAsia (www.e-tradeasia.com) is a well-established global B2B trade platform with millions of members and over 600,000 suppliers worldwide. The platform facilitates efficient matchmaking between buyers and sellers and maintains strategic partnerships with hundreds of trade organizations and exhibition entities globally. Through cross-platform marketing and integrated exposure, TradeAsia provides suppliers with expanded international visibility and multi-channel promotion opportunities. For ACI 2026, the organizers will implement a comprehensive global marketing campaign to support exhibitors in expanding overseas markets, enhancing brand presence, and maximizing business opportunities.

Media OutReach

ABP Securite Announces Strategic Partnership With Rapid7 to Enhance Cybersecurity in Asia Pacific

Published

8 hours ago

10/03/2026

Media Outreach

SINGAPORE – Media OutReach Newswire – 10 March 2026 – ABP Securite Pte Ltd, a global Value-Added Distributor (VAD) specialising in cybersecurity and network performance solutions, today announced a new strategic partnership with global cybersecurity company Rapid7, Inc. to accelerate the adoption of intelligence-led exposure management and modern threat detection solutions across Singapore and Malaysia.

The collaboration marks an important step in enabling enterprises to strengthen their security posture amid the region’s rapidly expanding digital landscape. With evolving hybrid infrastructures, accelerated cloud transformation, and increasing threat complexity, organisations across Asia Pacific are seeking more comprehensive ways to gain visibility, prioritise risk, and streamline response.

Under this partnership, ABP Securite will distribute and support Rapid7’s cybersecurity portfolio across Asia Pacific— including the Rapid7 Command Platform covering exposure management, SIEM and XDR, cloud security, application security, automation, and external threat intelligence.

Closing the Cyber Visibility Gap

“As the cybersecurity threat surface in Asia Pacific continues to grow, visibility and control have become mission critical,” said Joyce Ng, Chief Executive Officer of ABP Securite. “At ABP Securite, our role is to help customers turn complexity into clarity. Partnering with Rapid7 brings a best-in-class platform that empowers security teams to quantify and reduce risk more effectively. Together, we can help organisations operationalise cyber resilience and protect their most valuable assets.”

Jason Heng, Regional Sales Director, ASEAN at Rapid7, added, “ABP Securite has built a strong reputation for enabling regional partners and customers with advanced cybersecurity technologies. Through this collaboration, Rapid7 gains a powerful ally to extend our reach and help organisations in Asia Pacific gain real-time insight into their exposure, simplify operations, and respond faster to emerging threats.”

Hashtag: #ABPSecurite

The issuer is solely responsible for the content of this announcement.

About ABP Securite Pte Ltd

ABP Securite Pte Ltd is a leading cybersecurity and network-performance Value-Added Distributor (VAD), incorporated in 2015 and headquartered in Singapore, with regional offices across Asia Pacific. The company delivers a comprehensive portfolio of advanced security technologies and professional services — including architecture advisory, solution integration, after-sales support, and cloud-managed services. ABP Securite collaborates with a broad ecosystem of partners to help organisations strengthen cyber resilience, secure infrastructure, and protect critical assets across cloud, network, and data environments.
Website: www.abpsecurite.com

About Rapid7

Rapid7, Inc. (NASDAQ: RPD) is a global leader in AI-powered managed cybersecurity operations, trusted to advance organizations’ cyber resilience. Open and extensible, the Rapid7 Command Platform integrates security data, enriching it with AI, threat intelligence, and 25 years of expertise and innovation to reduce risk and disrupt attackers. As a recognized leader in preemptive managed detection and response (MDR), Rapid7 unifies exposure and detection to transform the cybersecurity operations of more than 11,500 customers worldwide. For more information, visit our website, check out our blog, or follow us on LinkedIn or X.